To further shed light on the role of VEGF in tumor angiogenesis and devise a therapeutic approach, human tumor-bearing mice were treated with an anti-VEGF neutralizing monoclonal antibody, which significantly suppressed the tumor growth in the mice (149). This evidence concerns the gene VEGFA and neoplasm.